First Tracks Biotherapeutics, Inc. (TRAX)

NASDAQ: TRAX · Real-Time Price · USD

18.16

-0.84 (-4.42%)

At close: Apr 24, 2026, 4:00 PM EDT

18.20

+0.04 (0.22%)

After-hours: Apr 24, 2026, 7:57 PM EDT

TRAX Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cost of Revenue	139.61	152.35	-
Gross Profit	-139.61	-152.35	-
Selling, General & Admin	39.39	28.76	20.87
Research & Development	-	-	90.26
Operating Expenses	39.39	28.76	111.12
Operating Income	-179.01	-181.1	-111.12
Interest & Investment Income	12.94	17.38	12.31
Other Non Operating Income (Expenses)	-0.02	0.01	-0
EBT Excluding Unusual Items	-166.09	-163.71	-98.81
Pretax Income	-166.09	-163.71	-106.15
Net Income	-166.09	-163.71	-106.15
Net Income to Common	-166.09	-163.71	-106.15
Free Cash Flow	-143.01	-126.16	-93.81
EBITDA	-178.45	-180.5	-110.47
D&A For EBITDA	0.56	0.61	0.65
EBIT	-179.01	-181.1	-111.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.